Morning Breakouts

Latest KFF Health News Stories

Thousands Of Government, Private Aid Officials To Meet In South Korea For Development Aid Summit

Morning Briefing

Thousands of government and private aid officials will meet in Busan, South Korea, on Tuesday for the beginning of the Fourth High Level Forum on Aid Effectiveness, which is “aimed at making sure billions of dollars in global aid money gets to the people who need it most,” the Associated Press/Washington Post reports (11/29). “U.S. Secretary of State Hillary Clinton and U.N. Secretary-General Ban Ki-moon will attend [the] summit in Busan, held against a backdrop of economic crisis in the United States and Europe and the rich world’s repeated failure to meet its targets for helping the poorest nations,” Reuters writes (Quinn, 11/28).

Tavenner Nomination Finds Support From Health Care Stakeholders

Morning Briefing

Also in the news, Politico examines Marilyn Tavenner’s political giving habits and CNN Money reports on the tenure of Donald Berwick, the exiting Centers of Medicare and Medicaid Services administrator.

Texas Pharmacists Assail Medicaid Cuts; Ariz. Could Restore Kids’ Coverage

Morning Briefing

The pharmacists say a plan to have health maintenance organizations manage the drug needs of Medicaid enrollees will drive them out of business. Meanwhile, Arizona officials announce a plan that will leverage federal Medicaid funds and allow them to restore insurance to some children who lost it in recent budget cuts.

Tricky Issues Surround Supreme Court’s Health Law Review

Morning Briefing

Should arguments heard by the high court regarding the health law be televised on C-SPAN? And should certain justices step away from the case? These are among the key questions that continue to buzz around the health law’s day in court.

Associated Press Examines Chinese Vaccine Makers’ Entry Into International Market

Morning Briefing

“China’s vaccine makers are gearing up over the next few years to push exports in a move that should lower costs of lifesaving immunizations for the world’s poor and provide major new competition for the big Western pharmaceutical companies,” the Associated Press reports in a feature examining the entry of Chinese vaccine makers into the international market. “China’s entry into this field is important because one child dies every 20 seconds from vaccine-preventable diseases each year,” the news agency writes, adding that the country’s “vaccine makers, some of whom already export in small amounts, are confident they will soon become big players in the field” (Wong, 11/29).

Al-Shabab Bans U.N., Other Aid Agencies From Working In Somalia; U.N. SG Condemns Actions

Morning Briefing

“Al-Shabab rebels banned some U.N. and international aid agencies from working in Somalia on Monday and began seizing and looting some of their offices in southern and central areas of the country, the Islamist group and aid sources said,” Reuters reports (Ahmed et al., 11/28). “Among the agencies al-Shabab banned on Monday were UNICEF, the World Health Organization, UNHCR, the Norwegian Refugee Council, the Danish Refugee Council, German Agency For Technical Cooperation (GTZ), Action Contre la Faim, Solidarity, Saacid and Concern,” the Associated Press/Washington Post notes (11/28). In a statement, al-Shabab, “[t]he main Islamist insurgent group in Somalia, which is still in the throes of a major food crisis classified as famine in some regions, … accus[ed] them of ‘illicit activities and misconduct,'” IRIN writes (11/28). “The al-Shabab statement accused the groups of exaggerating the scale of the problems in Somalia for political reasons and to raise money,” according to BBC News (11/28)

Testing Of Vaginal Gel For HIV Prevention Halted After Interim Results Showed No Difference From Placebo

Morning Briefing

Researchers involved with a multi-armed clinical trial designed to evaluate different antiretroviral (ARV) interventions for HIV prevention on Friday announced the arm testing a vaginal gel had been stopped because it was not working, the New York Times reports. The announcement marks “a major disappointment for AIDS research” because the gel “had seemed to work surprisingly well in a previous” trial, according to the newspaper. That study, called CAPRISA, found that the vaginal gel, which contains the ARV tenofovir, reduced the risk of HIV infection by 39 percent among women overall and by 54 percent among women who used it most consistently, the newspaper notes, adding, “It was hoped that the new trial, nicknamed VOICE (for Vaginal and Oral Interventions to Control the Epidemic), would confirm that earlier trial” (McNeil, 11/25).

IPS Examines Efforts To End Violence Against Women, Including U.N. Trust Fund And International Day

Morning Briefing

Inter Press Service profiles the United Nations Trust Fund to End Violence Against Women, writing, “Since it launched in 1997, [it] has distributed more than 78 million dollars to 339 projects around the world, but even these resources fall far short, meeting less than five percent of demand.” Noting that the Fund “provides services to women and girl survivors of violence, including legal aid, health care, shelter and psychosocial support,” the news service highlights a number of programs supported by the Fund through past grants and writes, “This year alone, more than 2,500 applications requesting about 1.2 billion dollars for programs across 123 countries have been received.”

Washington Must Lead Search For Additional Financing, More Cost-Effective Strategies In Fight Against AIDS

Morning Briefing

This New York Times editorial responds to the latest UNAIDS report (.pdf), which it says “reveals substantial success by some measures and stagnation by others,” writing, “The challenge, in tough times, that must be met is to find enough resources to capitalize on scientific breakthroughs and keep the campaign moving forward.”